[go: up one dir, main page]

RU2008105751A - METHOD FOR TREATING A PROGRESSING (ACTIVE) FORM OF SUBMACULAR NEOVASCULAR MEMBRANE (CHM) - Google Patents

METHOD FOR TREATING A PROGRESSING (ACTIVE) FORM OF SUBMACULAR NEOVASCULAR MEMBRANE (CHM) Download PDF

Info

Publication number
RU2008105751A
RU2008105751A RU2008105751/14A RU2008105751A RU2008105751A RU 2008105751 A RU2008105751 A RU 2008105751A RU 2008105751/14 A RU2008105751/14 A RU 2008105751/14A RU 2008105751 A RU2008105751 A RU 2008105751A RU 2008105751 A RU2008105751 A RU 2008105751A
Authority
RU
Russia
Prior art keywords
treating
active
course
days
chm
Prior art date
Application number
RU2008105751/14A
Other languages
Russian (ru)
Other versions
RU2372087C1 (en
Inventor
Александр Дмитриевич Чупров (RU)
Александр Дмитриевич Чупров
Мария Александровна Удачина (RU)
Мария Александровна Удачина
Константин Викторович Дмитриев (RU)
Константин Викторович Дмитриев
Original Assignee
Кировская клиническая офтальмологическая больница (RU)
Кировская клиническая офтальмологическая больница
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кировская клиническая офтальмологическая больница (RU), Кировская клиническая офтальмологическая больница filed Critical Кировская клиническая офтальмологическая больница (RU)
Priority to RU2008105751/14A priority Critical patent/RU2372087C1/en
Publication of RU2008105751A publication Critical patent/RU2008105751A/en
Application granted granted Critical
Publication of RU2372087C1 publication Critical patent/RU2372087C1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Способ лечения прогрессирующей (активной) формы субмакулярной неоваскулярной мембраны, отличающийся тем, что лекарственный препарат «Проспидин» вводится по 33 мг ретробульбарно 1 раз в день, курсом лечения 5-10 дней до лазеркоагуляции, и по 33 мг ретробульбарно 1 раз в день с первого дня после лазеркоагуляции, курсом лечения 5-10 дней, курс повторяется с интервалом 3 месяца.A method of treating a progressive (active) form of a submacular neovascular membrane, characterized in that the drug "Prospidin" is administered 33 mg retrobulbarly once a day, with a course of treatment 5-10 days before laser coagulation, and 33 mg retrobulbarly 1 time per day from the first days after laser coagulation, the course of treatment is 5-10 days, the course is repeated with an interval of 3 months.

Claims (1)

Способ лечения прогрессирующей (активной) формы субмакулярной неоваскулярной мембраны, отличающийся тем, что лекарственный препарат «Проспидин» вводится по 33 мг ретробульбарно 1 раз в день, курсом лечения 5-10 дней до лазеркоагуляции, и по 33 мг ретробульбарно 1 раз в день с первого дня после лазеркоагуляции, курсом лечения 5-10 дней, курс повторяется с интервалом 3 месяца. A method of treating a progressive (active) form of a submacular neovascular membrane, characterized in that the drug "Prospidin" is administered 33 mg retrobulbarly once a day, with a course of treatment 5-10 days before laser coagulation, and 33 mg retrobulbarly 1 time per day from the first days after laser coagulation, the course of treatment is 5-10 days, the course is repeated with an interval of 3 months.
RU2008105751/14A 2008-02-14 2008-02-14 Method of treating progressive (active) submacular neovascular membrane (snm) RU2372087C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2008105751/14A RU2372087C1 (en) 2008-02-14 2008-02-14 Method of treating progressive (active) submacular neovascular membrane (snm)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2008105751/14A RU2372087C1 (en) 2008-02-14 2008-02-14 Method of treating progressive (active) submacular neovascular membrane (snm)

Publications (2)

Publication Number Publication Date
RU2008105751A true RU2008105751A (en) 2009-08-20
RU2372087C1 RU2372087C1 (en) 2009-11-10

Family

ID=41150764

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008105751/14A RU2372087C1 (en) 2008-02-14 2008-02-14 Method of treating progressive (active) submacular neovascular membrane (snm)

Country Status (1)

Country Link
RU (1) RU2372087C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2440159C1 (en) * 2010-06-25 2012-01-20 Государственное образовательное учреждение высшего профессионального образования "Российский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО РГМУ Росздрава) Method of slowing down proliferation processes in injured retina

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2271208C2 (en) * 2003-03-31 2006-03-10 Кировская клиническая офтальмологическая больница Method for treating senile macular degeneration at neovascular syndrome

Also Published As

Publication number Publication date
RU2372087C1 (en) 2009-11-10

Similar Documents

Publication Publication Date Title
AU2019257489A1 (en) Rapid establishment and/or termination of substantial steady-state drug delivery
EA200802412A1 (en) THERAPEUTIC COMBINATIONS FOR SUPPORTING MEDICAL CONDITIONS
CR11723A (en) AGENT TO TREAT DISEASE
TW200507840A (en) Method of treating multiple myeloma
DK1750716T3 (en) Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin
DE602008003199D1 (en) GLUCOSEISOMERASE FOR THE TREATMENT OF FRUCTOSE INCOMPATIBILITY
RU2008105751A (en) METHOD FOR TREATING A PROGRESSING (ACTIVE) FORM OF SUBMACULAR NEOVASCULAR MEMBRANE (CHM)
RU2007122391A (en) S-MIRTAZAPINE FOR TIDAL TREATMENT
NO20070763L (en) Combination therapy with radiolabelled anti-CD20 antibody in the treatment of B-cell lymphoma
MX2010005009A (en) Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction.
RU2008129232A (en) METHOD FOR TREATING LUNG TUBERCULOSIS IN HIV-INFECT PATIENTS
RU2006146326A (en) METHOD FOR TREATING CHRONIC VIRAL HEPATITIS C
RU2008105750A (en) METHOD FOR TREATMENT OF STATIONARY (INACTIVE) FORM OF SUBMACULAR NEOVASCULAR MEMBRANE (CNM)
EA200701010A1 (en) HEPIRON PREPARATION WITH HIGH DOSAGE AND LONG-TERM LIBERATION
RU2004119923A (en) METHOD FOR TUBERCULOSIS TREATMENT
RU2007120403A (en) METHOD FOR LOCAL THERAPY OF AUTOIMMUNE ARTHRITIS
RU2010140179A (en) METHOD FOR TREATING PERIODONTITIS - METHOD OF JORDANISHVILI
RU2011148206A (en) METHOD FOR LYMPHOTROPIC THERAPY IN ORTHODENTAL ABSCESSES IN RABBITS
RU2007119243A (en) METHOD FOR CORRECTION OF ENDOGENOUS INTOXICATION AND PREVENTION OF UNWANTED ADVERSE REACTIONS OF ANTUBERCULOSIS DRUGS IN TUBERCULOSIS PATIENTS
RU2011108787A (en) METHOD FOR TREATING PATIENTS WITH RED PLANE
RU2007136579A (en) METHOD FOR TREATING HIV-INFECTED PATIENTS
DE602005011029D1 (en) THERAPEUTIC AGENT FOR THE TREATMENT OF PLASMA CELL TOPICAS
ATE491461T1 (en) COMBINATION DRUG FOR THE TREATMENT OF SEPSIS
RU2010128696A (en) METHOD FOR TREATING DermAL ANGIITS
RU2010136364A (en) METHOD FOR TREATING ALCOHOLIC, NICOTINE, DRUG AND OTHER FORMS OF DEPENDENCIES

Legal Events

Date Code Title Description
PC41 Official registration of the transfer of exclusive right

Effective date: 20101122

MM4A The patent is invalid due to non-payment of fees

Effective date: 20110215

NF4A Reinstatement of patent

Effective date: 20130227

MM4A The patent is invalid due to non-payment of fees

Effective date: 20140215

NF4A Reinstatement of patent

Effective date: 20150210